BioMark Diagnostics Inc.
BMKDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $35 | $32 | $23 | $18 |
| - Cash | $1 | $0 | $2 | $0 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | $35 | $32 | $21 | $18 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -82.4% | 0% | 1.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5,654.3% | -785.8% | -471.3% | -678.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7,006.2% | -1,066.9% | -1,082.1% | -868.1% |
| EPS Diluted | -0.01 | -0.004 | -0.005 | -0.004 |
| % Growth | -150% | 16.7% | -23.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |